ZONISAMIDE-13C2-15N
ZONISAMIDE-13C2-15N Basic information
- Product Name:
- ZONISAMIDE-13C2-15N
- Synonyms:
-
- ZONISAMIDE-13C2-15N
- 13C2,15N]-Zonisamide
- CAS:
- 1188265-58-8
- MF:
- C8H8N2O3S
- MW:
- 215.25
- Mol File:
- Mol File
ZONISAMIDE-13C2-15N Chemical Properties
- Melting point:
- 158 - 160°C
- storage temp.
- Refrigerator
- solubility
- DMSO (Sparingly), Methanol (Slightly)
- form
- Solid
- color
- Off-White to Light Yellow
ZONISAMIDE-13C2-15N Usage And Synthesis
Description
Zonisamide-13C2,15N is intended for use as an internal standard for the quantification of zonisamide by GC- or LC-MS. Zonisamide is an antiepileptic agent. It selectively inhibits the repeated firing of sodium channels (IC50 = 2 μg/ml) in mouse embryo spinal cord neurons and inhibits spontaneous channel firing when used at concentrations greater than 10 μg/ml. In rat cerebral cortex neurons, zonisamide (1-1,000 μM) inhibits T-type calcium channels with a maximum reduction of 60% of the calcium current. Zonisamide inhibits H. pylori recombinant carbonic anhydrase (CA) and the human CA isoforms I, II, and V with Ki values of 218, 56, 35, and 21 nM, respectively. In mice, it has anticonvulsant activity against maximal electroshock seizure (MES) and pentylenetetrazole-induced maximal, but not minimal, seizures (ED50s = 19.6, 9.3, and >500 mg/kg, respectively). Zonisamide (40 mg/kg, p.o.) prevents MPTP-induced decreases in the levels of dopamine , but not homovanillic acid (HVA; ) or dihydroxyphenyl acetic acid (DOPAC; ), and increases MPTP-induced decreases in the dopamine turnover rate in mouse striatum in a model of Parkinson''s disease. Formulations containing zonisamide have been used in the treatment of partial seizures in adults with epilepsy.
Uses
Zonisamide-13C2-15N is the labeled analogue of Zonisamide (Z700000), a sulfonamide antiseizure agent; blocks repetitive firing of voltagesensitive sodium channels and reduces voltage-sensitive T-type calcium currents. Heterocyclic methanesulfonide with anticonvulsant properties. The compound is under investigation for potential therapeutic use as an antiepileptic drug. Anticonvulsant.
ZONISAMIDE-13C2-15NSupplier
- Tel
- 010-82848833 400-666-7788
- jkinfo@jkchemical.com
- Tel
- 020-81960175
- min.he@cato-chem.com
- Tel
- 021-65675885 18964387627
- info@efebio.com
- Tel
- 02781293128
- orders@biochemsafebuy.com
- Tel
- 15374522761
- 3003392093@qq.com